Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NCT01031992Phase 3Completed
- Sponsor
- Saarland University Medical Center
- Start
- Mar 2002
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in hereditary hemorrhagic telangiectasia (HHT), sponsored by Saarland University Medical Center. Started Mar 2002; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT01031992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01031992.